Cited by 761Virus-based gene therapy researchRNA Interference and Gene DeliveryBacteriophages and microbial interactions

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Open access

Ferrari, F K, Samulski, T, Shenk, T, Samulski, R J·1996·Journal of Virology

DOI 10.1128/jvi.70.5.3227-3234.1996PMC PMC190186

Open this paper in CoChat — free account

Abstract

The ability of recombinant adeno-associated virus (AAV) to transduce cells with a marker gene in vitro was found to be substantially increased by the presence of adenovirus. Transfection experiments with adenovirus genomic DNA suggest that this increase is not facilitated by adenovirus-mediated viral uptake but is instead dependent on adenovirus gene expression. Using various adenovirus mutants, we were able to map this function to early-region E4 open reading frame 6. Plasmid expression of open reading frame 6 protein in cells infected with recombinant AAV increased transduction between 100- and 1,000-fold. The increase in transduction was not dependent on the recombinant AAV gene cassette but instead appeared to involve an immediate early step of the AAV life cycle. Chemical and physical agents that have been shown to induce helper-free replication of wild-type AAV were also able to stimulate recombinant AAV transduction, suggesting that the phenomenon might affect AAV DNA replication. Further experiments showed that viral uncoating was not affected and that the rate-limiting step involved synthesis of a second strand on the single-stranded genomic AAV DNA. These data suggest that the adenovirus E4 region, as well as chemical and physical agents, can play an essential role in an immediate-early step of the AAV life cycle, specifically in second-strand synthesis, and have important implications for the use of AAV vectors in gene therapy protocols.

Integrity signals

Registry

Crossref · 10.1128/jvi.70.5.3227-3234.1996

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L. R., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,116
Untitled work
(1952) · Cancer Research · Cited by 987
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Self-citation
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells
Jones, N. C., & Shenk, T. E. (1979) · Cell · doi:10.1016/0092-8674(79)90275-7 · Cited by 784
Self-citation
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Self-citation
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Self-citation

Show all 46 references

Sorted by citations

Items 101–200 of 758

Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus
Johnson, J. S., & Samulski, R. J. (2008) · Journal of Virology · doi:10.1128/jvi.02309-08 · Cited by 167
Self-citation
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
Zhang, Y., Li, H. Z., Min, Y.-L., Sanchez‐Ortiz, E., Huang, J. H., Mireault, A. A., Shelton, J. M., Kim, J., Mammen, P. P. A., Bassel‐Duby, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6812 · Cited by 165
Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo
Pernet, V., & Polo, A. D. (2006) · Brain · doi:10.1093/brain/awl015 · Cited by 160
Adeno-associated virus serotypes for gene therapeutics
Lisowski, L., Tay, S. S., & Alexander, I. E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.006 · Cited by 169
Adeno-associated virus vectors: activity and applications in the CNS
Peel, A. L., & Klein, R. L. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00183-7 · Cited by 155
Gene Transfer into Rat Mesenchymal Stem Cells: A Comparative Study of Viral and Nonviral Vectors
McMahon, J. M., Conroy, S., Lyons, M. J., Greiser, U., O'Shea, C. A., Strappe, P., Howard, L., Murphy, M. J., Barry, F., & O’Brien, T. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.87 · Cited by 156
Treatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose
Wu, Z., Sun, J., Zhang, T., Yin, C., Yin, F., Van Dyke, T., Samulski, R. J., & Monahan, P. E. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300355 · Cited by 153
Self-citation
Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats
Tomita, H., Sugano, E., Isago, H., Hiroi, T., Wang, Z., Ohta, E., & Tamai, M. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2009.12.006 · Cited by 148
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Tenenbaum, L., Lehtonen, E., & Monahan, P. E. (2003) · Current Gene Therapy · doi:10.2174/1566523034578131 · Cited by 146
Impaired Intracellular Trafficking of Adeno-Associated Virus Type 2 Vectors Limits Efficient Transduction of Murine Fibroblasts
Hansen, J. J., Qing, K., Kwon, H., Mah, C. S., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 147
A Dual Role of EGFR Protein Tyrosine Kinase Signaling in Ubiquitination of AAV2 Capsids and Viral Second-strand DNA Synthesis
Li, Z., Zhao, W., Wu, J., Li, B., Zolotukhin, S., Govindasamy, L., Agbandje‐McKenna, M., & Srivastava, A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300170 · Cited by 147
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR
Rohr, U., Wulf, M.-A., Stahn, S., Steidl, U. G., Haas, R. R., & Kronenwett, R. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00138-6 · Cited by 144
Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells
Maggio, I., Holkers, M., Liu, J., Janssen, J. M., Chen, X., & Gonçalves, M. A. F. V. (2014) · Scientific Reports · doi:10.1038/srep05105 · Cited by 139
Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular System
Zacchigna, S., Zentilin, L., & Giacca, M. (2014) · Circulation Research · doi:10.1161/circresaha.114.302331 · Cited by 144
Adeno-associated virus expression systems for gene transfer
Rabinowitz, J. E., & Samulski, J. R. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80031-1 · Cited by 140
Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid Uncoating and Genome Release
Horowitz, E. D., Rahman, K. S., Bower, B. D., Dismuke, D. J., Falvo, M. R., Griffith, J. D., Harvey, S. C., & Asokan, A. (2013) · Journal of Virology · doi:10.1128/jvi.03017-12 · Cited by 139
Roles of Adeno-Associated Virus Rep Protein and Human Chromosome 19 in Site-Specific Recombination
Young, S., McCarty, D. M., Degtyareva, N. P., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3953-3966.2000 · Cited by 138
Self-citation
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W. S., Warrington, K. H., Hearing, P., Hughes, J. A., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 142
Adeno-associated Virus as a Gene Therapy Vector: Vector Development, Production and Clinical Applications
Grieger, J. C., & Samulski, R. J. (2005) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_005 · Cited by 139
Self-citation
Adeno-associated virus vector integration junctions
Rutledge, E. A., & Russell, D. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8429-8436.1997 · Cited by 135
Adeno-associated virus 2 co-receptors?
Qiu, J., Mizukami, H., & Brown, K. E. (1999) · Nature Medicine · doi:10.1038/8328 · Cited by 135
Design and Packaging of Adeno-Associated Virus Gene Targeting Vectors
Hirata, R. K., & Russell, D. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4612-4620.2000 · Cited by 133
Adeno-Associated Virus Biology
Weitzman, M. D., & Linden, R. M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_1 · Cited by 132
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Kang, L., Jin, S., Wang, J., Lv, Z., Xin, C., Tan, C., Zhao, M., Wang, L., & Liu, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.067 · Cited by 131
Gene therapy: progress and predictions
Collins, M. K., & Thrasher, A. J. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.3003 · Cited by 145
HSV/AAV Hybrid Amplicon Vectors Extend Transgene Expression in Human Glioma Cells
Johnston, K. M., Jacoby, D. R., Pechan, P. A., Fraefel, C., Borghesani, P. R., Schuback, D. E., Dunn, R. J., Smith, F. I., & Breakefield, X. O. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.3-359 · Cited by 131
The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication
Schwartz, R. A., Palacios, J. A., Cassell, G. D., Adam, S., Giacca, M., & Weitzman, M. D. (2007) · Journal of Virology · doi:10.1128/jvi.01523-07 · Cited by 130
Nonrandom Transduction of Recombinant Adeno-Associated Virus Vectors in Mouse Hepatocytes In Vivo: Cell Cycling Does Not Influence Hepatocyte Transduction
Miao, C. H., Nakai, H., Thompson, A. R., Storm, T. A., Chiu, W. S., Snyder, R. O., & Kay, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3793-3803.2000 · Cited by 130
Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts
Hansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4080-4090.2001 · Cited by 129
CRISPR-READI: Efficient Generation of Knockin Mice by CRISPR RNP Electroporation and AAV Donor Infection
Chen, S., Sun, S., Moonen, D. P. I., Lee, C., Lee, A. Y.-F., Schaffer, D. V., & He, L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.103 · Cited by 133
Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked Ligands
Ponnazhagan, S., Mahendra, G., Kumar, S., Thompson, J. A., & Castillas, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12900-12907.2002 · Cited by 129
Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair
Cucchiarini, M., & Madry, H. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0125-2 · Cited by 133
Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury
Sapieha, P. S., Peltier, M., Rendahl, K. G., Manning, W. C., & Polo, A. D. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00228-8 · Cited by 128
Neonatal Intramuscular Injection with Recombinant Adeno-Associated Virus Results in Prolonged beta-Glucuronidase Expression in Situ and Correction of Liver Pathology in Mucopolysaccharidosis Type VII Mice
Daly, T. M., Okuyama, T., Vogler, C. A., Haskins, M. E., Muzyczka, N., & Sands, M. S. (1999) · Human Gene Therapy · doi:10.1089/10430349950019219 · Cited by 127
AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome
Wang, S., Li, Y., Xu, Y., Ma, Q., Lin, Z., Schlame, M., Bezzerides, V. J., Strathdee, D., & Pu, W. T. (2020) · Circulation Research · doi:10.1161/circresaha.119.315956 · Cited by 124
Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Cellular FKBP52 Protein in Transgene Expression
Qing, K., Hansen, J., Weigel-Kelley, K. A., Tan, M., Zhou, S., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8968-8976.2001 · Cited by 126
Time Course of Transgene Expression After Intrastriatal Pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 Transduction in the Rat
Reimsnider, S., Manfredsson, F. P., Muzyczka, N., & Mandel, R. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300227 · Cited by 125
Adeno-associated Virus Vectors in Gene Therapy
Mary, B., Khan, N., Arumugam, S., Saxena, H., Kumar, M., Manimaran, P., Chattopadhyay, S., & Jayandharan, G. R. (2018) · Springer eBooks · doi:10.1007/978-981-13-0481-1_2 · Cited by 126
Adeno-Associated Virus Gene Transfer to Mouse Retina
Ali, R. R., Reichel, M. B., de Alwis, M., Kanuga, N., Kinnon, C., Levinsky, R. J., Hunt, D. M., Bhattacharya, S. S., & Thrasher, A. J. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.1-81 · Cited by 125
Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
Grimm, D., & Kleinschmidt, J. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950016799 · Cited by 123
Journey to the Center of the Cell: Tracing the Path of AAV Transduction
Dhungel, B. P., Bailey, C. G., & Rasko, J. E. J. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.010 · Cited by 122
Clinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 123
Adeno-Associated Virus Type 2-Mediated Gene Transfer: Correlation of Tyrosine Phosphorylation of the Cellular Single-Stranded D Sequence-Binding Protein with Transgene Expression in Human Cells In Vitro and Murine Tissues In Vivo
Qing, K., Khuntirat, B., Mah, C. S., Kube, D. M., Wang, X.-S., Ponnazhagan, S., Zhou, S., Dwarki, V., Yöder, M. C., & Srivastava, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1593-1599.1998 · Cited by 121
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
Gaj, T., Epstein, B. E., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.151 · Cited by 124
Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system
Glatzel, M., Flechsig, E., Navarro, B., Klein, M. A., Paterna, J., Büeler, H., & Aguzzi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.442 · Cited by 119
Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions
Riyad, J. M., & Weber, T. (2021) · Gene Therapy · doi:10.1038/s41434-021-00243-z · Cited by 124
Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype
Grimm, D., Pandey, K., Nakai, H., Storm, T. A., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.426-439.2006 · Cited by 118
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
Qing, K., Wang, X.-S., Kube, D. M., Ponnazhagan, S., Bajpai, A., & Srivastava, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10879 · Cited by 118
Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors
Vassalli, G., Büeler, H., Dudler, J., von Segesser, . K., & KAPPENBERGER, L. J. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00554-5 · Cited by 117
Sustained expression of human factor VIII in mice using a parvovirus-based vector
Chao, H., Mao, L., Bruce, A. T., & Walsh, C. (2000) · Blood · doi:10.1182/blood.v95.5.1594.005k34_1594_1599 · Cited by 112
E4 gene function in adenovirus, adenovirus vector and adeno-associated virus infections.
Leppard, K. N. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-9-2131 · Cited by 114
Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation
Ponnazhagan, S., Mukherjee, P., Wang, X.-S., Qing, K., Kube, D. M., Mah, C. S., Kurpad, C., Yöder, M. C., Srour, E. F., & Srivastava, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8262-8267.1997 · Cited by 112
Structure of Adeno-Associated Virus Vector DNA following Transduction of the Skeletal Muscle
Vincent, N., Snyder, R. O., Gluzman, R., Bohl, D., Lagarde, C., & Danos, O. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1949-1955.1999 · Cited by 112
Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector
Ma, H.-I., Lin, S.-Z., Chiang, Y.-H., Li, J., Chen, S.-L., Tsao, Y.-P., & Xiao, X. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301616 · Cited by 110
New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors
Ferrari, F. K., Xiao, X., McCarty, D. M., & Samulski, R. J. (1997) · Nature Medicine · doi:10.1038/nm1197-1295 · Cited by 112
Self-citation
Adeno-Associated Viral Vectors for Gene Transfer and Gene Therapy
Büeler, H. (1999) · Biological Chemistry · doi:10.1515/bc.1999.078 · Cited by 112
Infection Efficiency of Human and Mouse Embryonic Stem Cells Using Adenoviral and Adeno-Associated Viral Vectors
Smith-Arica, J. R., Thomson, A. J., Ansell, R., Chiorini, J. A., Davidson, B. L., & McWhir, J. (2003) · Cloning and Stem Cells · doi:10.1089/153623003321512166 · Cited by 111
Adeno-associated virus vectors: potential applications for cancer gene therapy
Li, C., Bowles, D. E., Dyke, T. V., & Samulski, R. J. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700876 · Cited by 110
Self-citation
Scalable Generation of High-Titer Recombinant Adeno-Associated Virus Type 5 in Insect Cells
Urabe, M., Nakakura, T., Xin, K.-Q., Obara, Y., Mizukami, H., Kume, A., Kotin, R. M., & Ozawa, K. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1874-1885.2006 · Cited by 111
Methods for Gene Transfer to the Central Nervous System
Kantor, B., Bailey, R. M., Wimberly, K., Kalburgi, S. N., & Gray, S. J. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00003-2 · Cited by 109
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
Bartel, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00204 · Cited by 108
Self-Complementary Recombinant Adeno-Associated Viral Vectors: Packaging Capacity And The Role of Rep Proteins in Vector Purity
Wu, J., Zhao, W., Zhong, L., Han, Z., Li, B., Ma, W., Weigel-Kelley, K. A., Warrington, K. H., & Srivastava, A. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.088 · Cited by 108
Involvement of Cellular Double-Stranded DNA Break Binding Proteins in Processing of the Recombinant Adeno-Associated Virus Genome
Zentilin, L., Marcello, A., & Giacca, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12279-12287.2001 · Cited by 101
Gene Therapy in Retinal Dystrophies
Ziccardi, L., Cordeddu, V., Gaddini, L., Matteucci, A., Parravano, M., Malchiodi-Albedi, F., & Varano, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225722 · Cited by 107
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors
Kirik, D., & Björklund, A. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00164-4 · Cited by 108
Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products
Vincent, K. A., Piraino, S., & Wadsworth, S. C. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1897-1905.1997 · Cited by 104
Interactions of viruses with the cellular DNA repair machinery
Weitzman, M. D., Carson, C. T., Schwartz, R. A., & Lilley, C. E. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.018 · Cited by 107
Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction
Johnson, J. S., Li, C., DiPrimio, N., Weinberg, M. S., McCown, T. J., & Samulski, R. J. (2010) · Journal of Virology · doi:10.1128/jvi.00687-10 · Cited by 110
Self-citation
Adeno-associated virus-mediated gene delivery
Snyder, R. O. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3 · Cited by 106
Adeno‐associated virus vectors and hematology
Russell, D. W., & Kay, M. A. (1999) · Blood · doi:10.1182/blood.v94.3.864.415k34_864_874 · Cited by 104
Inhibition of S‐phase progression by adeno‐associated virus Rep78 protein is mediated by hypophosphorylated pRb
Saudan, P., Vlach, J., & Beard, P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4351 · Cited by 104
Disease-Inducible Transgene Expression from a Recombinant Adeno-Associated Virus Vector in a Rat Arthritis Model
Pan, R., Xiao, X., Chen, S., Li, J., Lin, L., Wang, H.-J., & Tsao, Y. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3410-3417.1999 · Cited by 104
Long-Term Efficacy of Adeno-Associated Virus Serotypes 8 and 9 in Hemophilia A Dogs and Mice
Sarkar, R., Mucci, M., Addya, S., Tetreault, R., Bellinger, D. A., Nichols, T. C., & Kazazian, H. H. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.427 · Cited by 102
Persistent expression of canine factor IX in hemophilia B canines
Chao, H., Samulski, R. J., Bellinger, D. A., Monahan, P. E., Nichols, T. C., & Walsh, C. E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301024 · Cited by 102
Self-citation
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction
Fisher-Adams, G., Wong, K. J., Podsakoff, G. M., Forman, S. J., & Chatterjee, S. (1996) · Blood · doi:10.1182/blood.v88.2.492.bloodjournal882492 · Cited by 103
Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Epidermal Growth Factor Receptor Protein Tyrosine Kinase in Transgene Expression
Mah, C. S., Qing, K., Khuntirat, B., Ponnazhagan, S., Wang, X.-S., Kube, D. M., Yöder, M. C., & Srivastava, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9835-9843.1998 · Cited by 102
An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells
Jang, J., Koerber, J. T., Kim, J., Asuri, P., Vazin, T., Bartel, M. A., Keung, A. J., Kwon, I., Park, K. I., & Schaffer, D. V. (2011) · Molecular Therapy · doi:10.1038/mt.2010.287 · Cited by 101
Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine
Joshi, J., Rubart, M., & Zhu, W. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00466 · Cited by 100
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction
Wang, J., Xie, J., Lu, H., Chen, L., Hauck, B., Samulski, R. J., & Xiao, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702778104 · Cited by 103
Self-citation
Synaptic Pathology in Retinoschisis Knockout ( Rs1 −/ y ) Mouse Retina and Modification by rAAV- Rs1 Gene Delivery
Takada, Y., Vijayasarathy, C., Zeng, Y., Kjellström, S., Bush, R. A., & Sieving, P. A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1071 · Cited by 100
A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction
Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Powell, S. K., Wright, J. F., & Kay, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11343-11349.2002 · Cited by 99
Intracellular Viral Processing, Not Single-Stranded DNA Accumulation, Is Crucial for Recombinant Adeno-Associated Virus Transduction
Hauck, B., Zhao, W., High, K. A., & Xiao, W. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13678-13686.2004 · Cited by 101
Adeno-associated viral vector transduction of human mesenchymal stem cells
Stender, S., Murphy, M. J., O’Brien, T., Stengaard, C., Ulrich‐Vinther, M., Søballé, K., & Barry, F. (2007) · European Cells and Materials · doi:10.22203/ecm.v013a10 · Cited by 98
AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Mitchell, A. M., Nicolson, S. C., Warischalk, J. K., & Samulski, R. J. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 97
Self-citation
Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase
Werfel, S., Jungmann, A., Lehmann, L., Ksienzyk, J., Bekeredjian, R., Kaya, Z., Leuchs, B., Nordheim, A., Backs, J., Engelhardt, S. H., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu174 · Cited by 94
In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors
Wright, M. J., Wightman, L., Lilley, C. E., de Alwis, M., Hart, S. L., Miller, A. D., Coffin, R. S., Thrasher, A. J., Latchman, D. S., & Marber, M. S. (2001) · Basic Research in Cardiology · doi:10.1007/s003950170053 · Cited by 94
Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease
Mandel, R. J., Snyder, R. O., & Leff, S. E. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7203 · Cited by 93
AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
Pattali, R. K., Mou, Y., & Li, X.-J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0085-4 · Cited by 100
Self-complementary AAV Virus (scAAV) Safe and Long-term Gene Transfer in the Trabecular Meshwork of Living Rats and Monkeys
Buie, L. K., Rasmussen, C. A., Porterfield, E. C., Ramgolam, V. S., Choi, V. W., Markovic‐Plese, S., Samulski, R. J., Kaufman, P. L., & Borrás, T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3847 · Cited by 96
Self-citation
Dissecting the Role of Subtypes of Gastrointestinal Vagal Afferents
Wang, Y. B., de Lartigue, G., & Page, A. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00643 · Cited by 98
Formation of Adeno-Associated Virus Circular Genomes Is Differentially Regulated by Adenovirus E4 ORF6 and E2a Gene Expression
Duan, D., Sharma, P., Dudus, L., Zhang, Y., Şanlıoğlu, S., Yan, Z., Yue, Y., Ye, Y., Lester, R., Yang, J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.161-169.1999 · Cited by 91
AAV Vector-mediated Reversal of Hypoglycemia in Canine and Murine Glycogen Storage Disease Type Ia
Koeberl, D. D., Pinto, C. R. F., Sun, B., Li, S., Kozink, D. M., Benjamin, D. K., DeMaster, A. K., Kruse, M. A., Vaughn, V. M., Hillman, S. L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.15 · Cited by 92
Applications of gene therapy to the CNS
Blömer, U., Naldini, L., Verma, I. M., Trono, D., & Gage, F. H. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1397 · Cited by 88
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0052-2014 · Cited by 93
Self-citation
Molecular regulation and biological function of adenovirus early genes: the E4 ORFs
Täuber, B., & Dobner, T. (2001) · Gene · doi:10.1016/s0378-1119(01)00722-3 · Cited by 86
Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle
Qiao, C., Zhang, W., Yuan, Z., Shin, J., Li, J., Jayandharan, G. R., Li, Z., Srivastava, A., Xiao, X., & Duan, D. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.003 · Cited by 85
Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: A strategy to increase opioid antinociception
Xu, Y., Gu, Y., Xu, G., Wu, P., Li, G.-W., & Huang, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0930324100 · Cited by 85
Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy
Şanlıoğlu, S., Monick, M. M., Lüleci, G., Hunninghake, G. W., & Engelhardt, J. F. (2001) · Current Gene Therapy · doi:10.2174/1566523013348788 · Cited by 85
Processing of recombinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins
Cervelli, T., Palacios, J. A., Zentilin, L., Mano, M., Schwartz, R. A., Weitzman, M. D., & Giacca, M. (2008) · Journal of Cell Science · doi:10.1242/jcs.003632 · Cited by 84

Authors: Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J.
Affiliations: University of North Carolina at Chapel Hill (US)
ORCID: Shenk, T
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 1996-05
Volume: 70
Issue: 5
Pages: 3227-3234
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.70.5.3227-3234.1996
PMC: PMC190186
OpenAlex: W2165815741
Cited by: 761
References: 46
Citations by year: 2026: 13 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 13 · 2021: 15 · 2020: 25 · 2019: 17 · 2018: 15 · 2017: 10 · 2016: 22 · 2015: 27 · 2014: 21 · 2013: 17 · 2012: 27
FWCI: 24.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01dk042701-06)
National Heart, Lung, and Blood Institute (HL48327, P01HL051818, HL51818)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 42701)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
Keywords: recombinant adeno-associated virus vectors, viral uncoating, gene therapy vectors
MeSH terms: Dependovirus, Adenoviridae, beta-Galactosidase, Cell Line, DNA, Viral, Genetic Vectors, HeLa Cells, Humans, Kinetics, Plasmids, Recombinant Proteins, Recombination, Genetic, Transduction, Genetic, Transfection, Ultraviolet Rays, X-Rays, Gene Expression, Mutagenesis, Open Reading Frames

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks